Frontier Capital Management CO LLC Kymera Therapeutics, Inc. Transaction History
Frontier Capital Management CO LLC
- $9.96 Billion
- Q3 2024
A detailed history of Frontier Capital Management CO LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 392,263 shares of KYMR stock, worth $15.1 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
392,263Holding current value
$15.1 Million% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
64.3MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$256 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$231 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$199 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$188 Million28.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$183 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.11B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...